Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Overview of the 2022 WHO classification of thyroid neoplasms
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
Pathogenesis of cancers derived from thyroid follicular cells
The genomic simplicity of differentiated cancers derived from thyroid follicular cells offers
unique insights into how oncogenic drivers impact tumour phenotype. Essentially, the main …
unique insights into how oncogenic drivers impact tumour phenotype. Essentially, the main …
[PDF][PDF] Guidelines for the management of thyroid cancer.
Guidelines for the management of thyroid cancer Page 1 CLINICAL ENDOCRINOLOGY
VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF THE SOCIETY FOR …
VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF THE SOCIETY FOR …
Mitochondrial dysfunction: a novel potential driver of epithelial-to-mesenchymal transition in cancer
Epithelial-to-mesenchymal transition (EMT) allows epithelial cancer cells to assume
mesenchymal features, endowing them with enhanced motility and invasiveness, thus …
mesenchymal features, endowing them with enhanced motility and invasiveness, thus …
Clinical and molecular features of Hürthle cell carcinoma of the thyroid
Context: Hürthle cell cancer (HCC) of the thyroid remains the subject of controversy with
respect to natural course, treatment, and follow-up. Objective: The objective of the study was …
respect to natural course, treatment, and follow-up. Objective: The objective of the study was …
Real-world performance of the Afirma Genomic Sequencing Classifier (GSC)—a meta-analysis
CE Nasr, M Andrioli, M Endo, RM Harrell… - The Journal of …, 2023 - academic.oup.com
Abstract Context The Afirma® GSC aids in risk stratifying indeterminate thyroid nodule
cytology (ITN). The 2018 GSC validation study (VS) reported a sensitivity (SN) of 91 …
cytology (ITN). The 2018 GSC validation study (VS) reported a sensitivity (SN) of 91 …
Molecular alterations and comprehensive clinical management of oncocytic thyroid carcinoma: a review and multidisciplinary 2023 update
Importance Oncocytic (Hürthle cell) thyroid carcinoma is a follicular cell-derived neoplasm
that accounts for approximately 5% of all thyroid cancers. Until recently, it was categorized …
that accounts for approximately 5% of all thyroid cancers. Until recently, it was categorized …
[HTML][HTML] Thyroid Hürthle cell carcinoma: clinical, pathological, and molecular features
Simple Summary Hürthle cell carcinoma (HCC) represents 3–4% of thyroid carcinoma
cases. It is characterized by its large, granular and eosinophilic cytoplasm, due to an …
cases. It is characterized by its large, granular and eosinophilic cytoplasm, due to an …
Pathology of endocrine tumors update: World Health Organization new classification 2017—other thyroid tumors
The data on nonmedullary thyroid tumors in the fourth edition of the World Health
Organization classification of endocrine tumors contain significant revisions. The tumors …
Organization classification of endocrine tumors contain significant revisions. The tumors …
PET/CT in the management of thyroid cancers
OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates
the established use of 18F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and …
the established use of 18F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and …